Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00825747

Evaluation of Seelens AF, an Aspheric Intra-ocular Lens

Clinical Evaluation of the Aspheric SeeLens AF Intra-ocular Lens.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Hanita Lenses · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Senile cataract is managed by cataract extraction and intra-ocular lens (IOL) implantation. The purpose of this study is to evaluate the safety and efficacy of the SeeLens AF, an acrylic hydrophilic aspheric IOL. This lens was designed to reduce vision aberrations and secondary cataract formation rate. Preoperative evaluation: Best corrected visual acuity, refraction, comprehensive slit lamp examination and biometry. Surgical procedure: Cataract surgery using a clear corneal incision (1.8mm to2.4mm), phacoemulsification and implantation of the SeeLens AF to the capsular bag. IOL implantation parameters will be evaluated by the surgeon. Postoperative follow up: Best corrected visual acuity, uncorrected visual acuity, refraction and comprehensive slit lamp examinations up to 3 months after surgery.

Conditions

Interventions

TypeNameDescription
DEVICESeeLens AF intra-ocular lensthe SeeLens AF is an acrylic hydrophilic C shaped haptics intra-ocular lens, designed for implantation in the lenticular capsular bag or the sulcus during cataract surgery.

Timeline

Start date
2009-01-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2009-01-21
Last updated
2021-04-13

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT00825747. Inclusion in this directory is not an endorsement.